Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalation for Larger Brain Metastases: Phase I/II Study

NCT01843413 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT01843413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01843413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalation for Larger Brain Metastases: Phase I/II Study
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 2, 2013
Completion date
August 31, 2025
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tumors metastatic to brain, unspecified adult solid tumor